StockData
Aytu BioPharma, Inc logo

Aytu BioPharma, Inc (AYTU) stock

AYTUNasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3070% below fair value
$2.66+0.00 (0.00%)

Close on Nov 18, 2026Market cap $28.91MP/E –Yield –

Aytu BioPharma pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Aytu BioPharma's pe ratio was 9.2× on Jul 31, 2025.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Jul 31, 20259.2×–

More Aytu BioPharma figures

See a number that looks wrong?